featured
Lenvatinib Plus Pembrolizumab for Advanced Endometrial Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer
N. Engl. J. Med 2022 Jan 19;[EPub Ahead of Print], V Makker, N Colombo, A Casado Herráez, AD Santin, E Colomba, DS Miller, K Fujiwara, S Pignata, S Baron-Hay, I Ray-Coquard, R Shapira-Frommer, K Ushijima, J Sakata, K Yonemori, YM Kim, EM Guerra, UA Sanli, MM McCormack, AD Smith, S Keefe, S Bird, L Dutta, RJ Orlowski, D LorussoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.